Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
7,926
+24
+0.3% +$2.81K 0.62% 44
2026
Q1
$951K Buy
7,902
+103
+1% +$11.9K 0.68% 43
2025
Q4
$821K Buy
7,799
+100
+1% +$9.39K 0.62% 49
2025
Q3
$646K Hold
7,699
0.5% 61
2025
Q2
$609K Buy
+7,699
New +$612K 0.51% 61

Other funds holding MRK

Rexford Capital's MRK Position: Q2 2026 in Review

Rexford Capital increased its Merck (MRK) stake by 0.3% in Q2 2026, buying an estimated $2.81K and bringing the position to 7,926 shares worth $1.02M. The position accounts for 0.62% of the portfolio, ranked #44.

Rexford Capital first reported a position in MRK in Q2 2025 and has held it in 5 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Rexford Capital held 7,926 shares of Merck worth $1.02M as of Q2 2026.
  • Rexford Capital bought 24 Merck shares in Q2 2026, an estimated $2.81K.
  • Merck made up 0.62% of Rexford Capital's portfolio in Q2 2026, its #44 holding.
  • Rexford Capital first reported a position in Merck in Q2 2025 and has held it in 5 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Rexford Capital's 13F filing for Q2 2026, filed 29 Jul 2026.